Zalutumumab plus best supportive care versus best supportive care alone in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy: an open-label, randomised phase 3 trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Keywords: epidermal growth factor receptor, head and neck squamous cell carcinoma, recurrent or metastatic cancer, platinum-refractory disease, best supportive care, methotrexate, overall survival, progression-free survival, monoclonal antibodies, treatment safety, rash, dose titration, performance status, treatment-related adverse events
Open Access status: closed
OpenAlex ID: W2140747142
